These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39308406)
1. Evaluation of Multigene Methylation for Blood-Based Detection of Colorectal Cancer. Xu Y; Tan A; Liang R; Qu H; Li X; Wang Z Genet Test Mol Biomarkers; 2024 Oct; 28(10):402-409. PubMed ID: 39308406 [No Abstract] [Full Text] [Related]
2. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer. Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948 [TBL] [Abstract][Full Text] [Related]
3. The value of SDC2 and Septin9 combined with serum tumor markers in early diagnosis of colorectal cancer. Zou CS; Xie YL; Wang DX; Liu YP; Li MQ; Chen Y; Su ZL; Liu KH Int J Colorectal Dis; 2024 Sep; 39(1):142. PubMed ID: 39289219 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer. Sun Q; Long L BMC Cancer; 2024 Jul; 24(1):906. PubMed ID: 39068425 [TBL] [Abstract][Full Text] [Related]
5. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480 [TBL] [Abstract][Full Text] [Related]
6. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855 [TBL] [Abstract][Full Text] [Related]
7. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations. Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698 [TBL] [Abstract][Full Text] [Related]
8. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test. Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of quantifying Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717 [TBL] [Abstract][Full Text] [Related]
10. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis. Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710 [TBL] [Abstract][Full Text] [Related]
12. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903 [TBL] [Abstract][Full Text] [Related]
14. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. Li B; Liu S; Gao Y; Zheng L; Lu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460 [TBL] [Abstract][Full Text] [Related]
15. A novel dual-target Septin9 methylation assay for improved detection of early-stage colorectal cancer and high-grade intraepithelial neoplasia. Wu Y; Tong Y; Zhang H; Li Y; Zhu X; Li M; Qiu L; Liu W; Mei S; Mao Y; Cao Y; Su C; Yu W; Wang J; Wang T; Zhu Z; Yu DH BMC Cancer; 2024 Jul; 24(1):916. PubMed ID: 39080571 [TBL] [Abstract][Full Text] [Related]
16. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908 [TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. Young GP; Pedersen SK; Mansfield S; Murray DH; Baker RT; Rabbitt P; Byrne S; Bambacas L; Hollington P; Symonds EL Cancer Med; 2016 Oct; 5(10):2763-2772. PubMed ID: 27726312 [TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial. Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988 [TBL] [Abstract][Full Text] [Related]
20. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis. Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]